KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATFurniture, Fixtures and OtherLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares IssuedShort-Term Debt repayments
Ratios

Boston Scientific (BSX) Accumulated Depreciation & Amortization (2016 - 2025)

Boston Scientific (BSX) has disclosed Accumulated Depreciation & Amortization for 17 consecutive years, with $1.4 billion as the latest value for Q4 2025.

  • Quarterly Accumulated Depreciation & Amortization rose 7.8% to $1.4 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.4 billion through Dec 2025, up 7.8% year-over-year, with the annual reading at $1.4 billion for FY2025, 7.8% up from the prior year.
  • Accumulated Depreciation & Amortization hit $1.4 billion in Q4 2025 for Boston Scientific, up from $1.0 billion in the prior quarter.
  • In the past five years, Accumulated Depreciation & Amortization ranged from a high of $1.4 billion in Q4 2025 to a low of $268.0 million in Q1 2021.
  • Historically, Accumulated Depreciation & Amortization has averaged $745.9 million across 5 years, with a median of $732.0 million in 2021.
  • Biggest five-year swings in Accumulated Depreciation & Amortization: decreased 3.8% in 2021 and later increased 8.9% in 2025.
  • Year by year, Accumulated Depreciation & Amortization stood at $1.1 billion in 2021, then increased by 3.93% to $1.1 billion in 2022, then increased by 5.28% to $1.2 billion in 2023, then increased by 6.1% to $1.3 billion in 2024, then rose by 7.8% to $1.4 billion in 2025.
  • Business Quant data shows Accumulated Depreciation & Amortization for BSX at $1.4 billion in Q4 2025, $1.0 billion in Q3 2025, and $661.0 million in Q2 2025.